Anti-Rabies Vaccine Schedule
For previously unvaccinated persons exposed to rabies, administer a 4-dose vaccine series on days 0,3,7, and 14, combined with rabies immune globulin (RIG) on day 0; immunocompromised patients require a 5-dose series with an additional dose on day 28. 1
Post-Exposure Prophylaxis for Unvaccinated Persons
The standard regimen consists of three critical components that must be initiated immediately after exposure:
Wound Care
- Begin with thorough cleansing of all wounds with soap and water
- Use a virucidal agent (povidone-iodine solution) to irrigate wounds if available 1
Human Rabies Immune Globulin (HRIG)
- Dose: 20 IU/kg body weight, administered once on day 0 1
- Administration technique: Infiltrate the full dose around and into the wound(s) if anatomically feasible; inject any remaining volume intramuscularly at a site distant from vaccine administration 1
- Critical timing: If not given on day 0, HRIG can be administered up to and including day 7 of the vaccine series 1
- Important caveat: Never administer HRIG in the same syringe or at the same anatomic site as the vaccine, as it may partially suppress active antibody production 1
Vaccine Schedule
Standard 4-dose regimen (for immunocompetent patients):
- 1.0 mL intramuscularly on days 0,3,7, and 14 1
- Use either Human Diploid Cell Vaccine (HDCV) or Purified Chick Embryo Cell Vaccine (PCECV) 1
- Day 0 is defined as the day the first vaccine dose is administered 1
Modified 5-dose regimen (for immunocompromised patients):
- 1.0 mL intramuscularly on days 0,3,7,14, and 28 1
- This extended schedule is essential for patients with any form of immunosuppression 1
Injection Site Specifications
- Adults and older children: Deltoid area only 1
- Younger children: Outer aspect of the thigh is acceptable 1
- Never use the gluteal area: This site results in diminished immunologic response 1
- Dose is the same for all ages: Children receive the identical 1.0 mL volume as adults 1
Post-Exposure Prophylaxis for Previously Vaccinated Persons
Previously vaccinated individuals require only 2 vaccine doses on days 0 and 3, with NO rabies immune globulin. 1
Definition of "Previously Vaccinated"
A person qualifies as previously vaccinated if they have:
- Received ACIP-recommended pre-exposure vaccination with HDCV, PCECV, or rabies vaccine adsorbed (RVA), OR
- Received prior post-exposure prophylaxis with these vaccines, OR
- Received any other rabies vaccine with documented adequate antibody response 1
Simplified Regimen
- Vaccine only: 1.0 mL intramuscularly on days 0 and 3 1
- No HRIG: Immune globulin should NOT be administered, as it may inhibit the anamnestic response 1
- Wound care: Still perform thorough wound cleansing with soap and water, preferably with virucidal agent 1
Key Clinical Pitfalls to Avoid
Never delay initiation: Begin post-exposure prophylaxis as soon as possible after exposure, regardless of time interval since exposure 1
Do not exceed recommended HRIG dose: More than 20 IU/kg may suppress active antibody production 1
Avoid gluteal injection: This anatomic site consistently produces inadequate immune responses 1
Do not give HRIG to previously vaccinated persons: This will interfere with their rapid anamnestic response 1
Recognize immunocompromised patients early: They require the 5-dose extended schedule from the outset 1
HRIG timing window: If missed on day 0, you have until day 7 to administer it 1
Evidence Quality and Rationale
The 4-dose schedule represents a reduction from the previous 5-dose regimen based on evidence showing equivalent immunogenicity with cost savings of approximately $16.6 million to the U.S. healthcare system 1. This guideline from the Advisory Committee on Immunization Practices (ACIP) is the authoritative standard for rabies post-exposure prophylaxis in the United States 1. The evidence demonstrates that when used appropriately with timely wound care and HRIG administration, the 4-dose vaccine schedule induces adequate, long-lasting antibody responses capable of neutralizing rabies virus and preventing disease 2.
The critical distinction for immunocompromised patients requiring 5 doses reflects the need for enhanced immune stimulation in this vulnerable population, ensuring adequate protection despite impaired immune function 1.